Uemura Motohide

ウエムラモトヒデ | Uemura Motohide

Research field (1)： Medical biochemistry

Research theme for competitive and other funds (18)：

2022 - 2025 時空間内包型数理的解析手法によるがん細胞のクロナリティの新たな理解
2021 - 2024 大阪臨床研究ネットワーク基盤を利用した新規骨転移血液バイオマーカーの多施設研究
2021 - 2024 DNA損傷応答に着目した機能喪失スクリーニングによる前立腺癌の新規治療法の開発
2020 - 2023 腎癌の循環腫瘍DNAによる変異プロファイル進化の解明と個別化医療への臨床応用
2020 - 2023 Establishment of precisoin medicine for malti-omics approaches using cancer tissue

Show all

Papers (423)：

Yujiro Kidani, Yohko Kitagawa, Masaki Hagiwara, Atsunari Kawashima, Takayuki Kanazawa, Hisashi Wada, Motohide Uemura, Norio Nonomura, Daisuke Motooka, Shota Nakamura, et al. Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function. International Immunology. 2024. 36. 4. 167-182
Yujiro Kidani, Yohko Kitagawa, Masaki Hagiwara, Atsunari Kawashima, Takayuki Kanazawa, Hisashi Wada, Motohide Uemura, Norio Nonomura, Daisuke Motooka, Shota Nakamura, et al. Downregulation of TCF7 and LEF1 is a key determinant of tumor-infiltrating regulatory T-cell function. International immunology. 2024. 36. 4. 167-182
Gaku Yamamichi, Taigo Kato, Tadashi Watabe, Koji Hatano, Motohide Uemura, Norio Nonomura. Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate Cancer. Anticancer research. 2024. 44. 3. 879-888
Naoki Tsuchiya, Koichiro Kimura, Ukihide Tateishi, Tadashi Watabe, Koji Hatano, Motohide Uemura, Norio Nonomura, Akinobu Shimizu. Detection support of lesions in patients with prostate cancer using [Formula: see text]-PSMA 1007 PET/CT. International journal of computer assisted radiology and surgery. 2024
Juntaro Koyama, Shinichi Yamashita, Kenichi Kakimoto, Motohide Uemura, Takeshi Kishida, Koji Kawai, Terukazu Nakamura, Takayuki Goto, Takahiro Osawa, Kazuo Nishimura, et al. Sexual function using the EORTC QLQ-TC26 in testicular cancer survivors: A multi-institutional, cross-sectional study. International journal of urology : official journal of the Japanese Urological Association. 2023. 30. 11. 1044-1050

ｍore...

MISC (293)：

川田哲史, 小澤純二, 米田祥, 藤田有可里, 高山理佐, 木村武量, 細川吉弥, 馬殿恵, 宇野彩, 上中理香子, et al. 免疫チェックポイント阻害薬関連1型糖尿病の発症には膵島でのPD-L1発現低下、炎症細胞浸潤、疾患感受性HLAが関連する. 日本内分泌学会雑誌. 2023. 99. 1. 371-371
川田哲史, 小澤純二, 米田祥, 藤田有可里, 高山理佐, 木村武量, 細川吉弥, 馬殿恵, 宇野彩, 上中理香子, et al. 免疫チェックポイント阻害薬関連1型糖尿病の発症には膵島でのPD-L1発現低下,炎症細胞浸潤,疾患感受性HLAが関連する. 糖尿病. 2023. 66. Suppl.1. S-147
山道岳, 加藤大悟, 本山雄一, 王谷英達, 明庭昇平, 冨山栄輔, 石津谷祐, 山本致之, 波多野浩士, 河嶋厚成, et al. GDPP is a novel blood biomarker in bone metastasis of prostate cancer by fueling the vicious cycle. 日本泌尿器科学会総会(Web). 2023. 110th
Taigo Kato, Kazuma Kiyotani, Akinaru Yamamoto, Toshihiro Uemura, Gaku Yamamichi, Eisuke Tomiyama, Yoko Koh, Makoto Matsushita, Koji Hatano, Atsunari Kawashima, et al. Early dynamics of T cell clonotypes as potential surrogate biomarker for immune checkpoint inhibitors. CANCER SCIENCE. 2022. 113
Motohide Uemura, Noboru Nakaigawa, Naoto Sassa, Katsunori Tatsugami, Kenichi Harada, Toshinari Yamasaki, Nobuaki Matsubara, Takuya Yoshimoto, Yuki Nakagawa, Tamaki Fukuyama, et al. Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma (Jul, 10.1007/s10147-021-01993-x, 2021). INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 2021

ｍore...

Lectures and oral presentations (273)：

前立腺肉腫術後局所再発とリンパ節転移に対して化学療法後、重粒子線治療を併用し完全寛解を得た1例
(泌尿器科紀要 2018)
生体腎移植術を施行した、新規MUC1遺伝子変異を有する家族性尿細管間質性腎炎の1例
(泌尿器科紀要 2018)
尿道部分切除術を行い陰茎を温存しえた尿道癌の1例
(泌尿器科紀要 2018)
T1 high grade膀胱癌に対するBCG治療後に出現した孤発性骨盤内リンパ節転移に対し膀胱温存をしえた2例
(泌尿器科紀要 2018)
癌組織内浸潤CD4+CD8+T細胞の検討
(日本外科学会定期学術集会抄録集 2018)

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page